BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 26852686)

  • 1. Multiple pathways regulate Cten in colorectal cancer without a Tensin switch.
    Thorpe H; Akhlaq M; Jackson D; Al Ghamdi S; Storr S; Martin S; Ilyas M
    Int J Exp Pathol; 2015 Dec; 96(6):362-9. PubMed ID: 26852686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-terminal tensin-like protein mediates invasion of human lung cancer cells and is regulated by signal transducer and activator of transcription 3.
    Bennett DT; Reece TB; Foley LS; Sjoberg A; Meng X; Fullerton DA; Weyant MJ
    J Thorac Cardiovasc Surg; 2015 Jan; 149(1):369-75. PubMed ID: 25439778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cten is targeted by Kras signalling to regulate cell motility in the colon and pancreas.
    Al-Ghamdi S; Albasri A; Cachat J; Ibrahem S; Muhammad BA; Jackson D; Nateri AS; Kindle KB; Ilyas M
    PLoS One; 2011; 6(6):e20919. PubMed ID: 21698197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cten signals through integrin-linked kinase (ILK) and may promote metastasis in colorectal cancer.
    Albasri A; Al-Ghamdi S; Fadhil W; Aleskandarany M; Liao YC; Jackson D; Lobo DN; Lo SH; Kumari R; Durrant L; Watson S; Kindle KB; Ilyas M
    Oncogene; 2011 Jun; 30(26):2997-3002. PubMed ID: 21339732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TGFβ1-induced cell motility but not cell proliferation is mediated through Cten in colorectal cancer.
    Asiri A; Raposo TP; Alfahed A; Ilyas M
    Int J Exp Pathol; 2018 Dec; 99(6):323-330. PubMed ID: 30648319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A reciprocal tensin-3-cten switch mediates EGF-driven mammary cell migration.
    Katz M; Amit I; Citri A; Shay T; Carvalho S; Lavi S; Milanezi F; Lyass L; Amariglio N; Jacob-Hirsch J; Ben-Chetrit N; Tarcic G; Lindzen M; Avraham R; Liao YC; Trusk P; Lyass A; Rechavi G; Spector NL; Lo SH; Schmitt F; Bacus SS; Yarden Y
    Nat Cell Biol; 2007 Aug; 9(8):961-9. PubMed ID: 17643115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CTEN prolongs signaling by EGFR through reducing its ligand-induced degradation.
    Hong SY; Shih YP; Li T; Carraway KL; Lo SH
    Cancer Res; 2013 Aug; 73(16):5266-76. PubMed ID: 23774213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-terminal tensin-like gene functions as an oncogene and promotes cell motility in pancreatic cancer.
    Al-Ghamdi S; Cachat J; Albasri A; Ahmed M; Jackson D; Zaitoun A; Guppy N; Otto WR; Alison MR; Kindle KB; Ilyas M
    Pancreas; 2013 Jan; 42(1):135-40. PubMed ID: 22750970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-terminal tensin-like (CTEN): a promising biomarker and target for cancer.
    Lo SH
    Int J Biochem Cell Biol; 2014 Jun; 51():150-4. PubMed ID: 24735711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-terminal Tensin-like (CTEN) is an oncogene which alters cell motility possibly through repression of E-cadherin in colorectal cancer.
    Albasri A; Seth R; Jackson D; Benhasouna A; Crook S; Nateri AS; Chapman R; Ilyas M
    J Pathol; 2009 May; 218(1):57-65. PubMed ID: 19214987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Constitutively active Stat3 enhances neu-mediated migration and metastasis in mammary tumors via upregulation of Cten.
    Barbieri I; Pensa S; Pannellini T; Quaglino E; Maritano D; Demaria M; Voster A; Turkson J; Cavallo F; Watson CJ; Provero P; Musiani P; Poli V
    Cancer Res; 2010 Mar; 70(6):2558-67. PubMed ID: 20215508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cten, a COOH-terminal tensin-like protein with prostate restricted expression, is down-regulated in prostate cancer.
    Lo SH; Lo TB
    Cancer Res; 2002 Aug; 62(15):4217-21. PubMed ID: 12154022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cten promotes Epithelial-Mesenchymal Transition (EMT) in colorectal cancer through stabilisation of Src.
    Asiri A; Toss MS; Raposo TP; Akhlaq M; Thorpe H; Alfahed A; Asiri A; Ilyas M
    Pathol Int; 2019 Jul; 69(7):381-391. PubMed ID: 31290243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CTEN/tensin 4 expression induces sensitivity to paclitaxel in prostate cancer.
    Li Y; Mizokami A; Izumi K; Narimoto K; Shima T; Zhang J; Dai J; Keller ET; Namiki M
    Prostate; 2010 Jan; 70(1):48-60. PubMed ID: 19725034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cten promotes epithelial-mesenchymal transition through the post-transcriptional stabilization of Snail.
    Thorpe H; Asiri A; Akhlaq M; Ilyas M
    Mol Carcinog; 2017 Dec; 56(12):2601-2609. PubMed ID: 28691764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ΔNp63α Transcriptionally Regulates the Expression of CTEN That Is Associated with Prostate Cell Adhesion.
    Yang K; Wu WM; Chen YC; Lo SH; Liao YC
    PLoS One; 2016; 11(1):e0147542. PubMed ID: 26784942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. STAT3 exacerbates survival of cancer stem-like tumorspheres in EGFR-positive colorectal cancers: RNAseq analysis and therapeutic screening.
    Cheng CC; Liao PN; Ho AS; Lim KH; Chang J; Su YW; Chen CG; Chiang YW; Yang BL; Lin HC; Chang YC; Chang CC; Chang YF
    J Biomed Sci; 2018 Aug; 25(1):60. PubMed ID: 30068339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EGF-Induced Acetylation of Heterogeneous Nuclear Ribonucleoproteins Is Dependent on KRAS Mutational Status in Colorectal Cancer Cells.
    Roda D; Castillo J; Telechea-Fernández M; Gil A; López-Rodas G; Franco L; González-Rodríguez P; Roselló S; Pérez-Fidalgo JA; García-Trevijano ER; Cervantes A; Zaragozá R
    PLoS One; 2015; 10(6):e0130543. PubMed ID: 26110767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigating TNS4 in the Colorectal Tumor Microenvironment Using 3D Spheroid Models of Invasion.
    Raposo TP; Susanti S; Ilyas M
    Adv Biosyst; 2020 Jun; 4(6):e2000031. PubMed ID: 32390347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual targeting of the epidermal growth factor receptor using the combination of cetuximab and erlotinib: preclinical evaluation and results of the phase II DUX study in chemotherapy-refractory, advanced colorectal cancer.
    Weickhardt AJ; Price TJ; Chong G; Gebski V; Pavlakis N; Johns TG; Azad A; Skrinos E; Fluck K; Dobrovic A; Salemi R; Scott AM; Mariadason JM; Tebbutt NC
    J Clin Oncol; 2012 May; 30(13):1505-12. PubMed ID: 22412142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.